Priya Singhal

Head of Development, Biogen

Bought, 12 months

$0.0M

Sold, 12 months

$0.7M

Companies

Latest trade

Feb 9, 2026

Companies

BiogenHead of Development −$0.7M

Trades

BIIB Sold 2,660 shares at $199.83 · planned $0.5M Feb 9

BIIB Sold 748 shares at $179.30 · planned $0.1M Feb 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.